Krka’s Consecutive Growth Fuels Investment Plans

Company’s 2020 Plan Projects Sales At €1.5bn

Given the consecutive growth Krka has seen in its prescription pharmaceuticals portfolio along with an increase in overall sales, the company has announced investments of €134m in infrastructure and production facilities. This follows a €30m investment in the first half of 2020.

Watering_Plant
After investing €30m in the first half of 2020, Krka announces further investment of €134m • Source: Shutterstock

Keeping in line with the growth trend seen in the first quarter of 2020, Krka Group has reported a 6% boost of €42.4m ($48.5m) in overall sales to €803.8m in the first half of 2020, compared with the corresponding period of 2019. 

Krka reported an increase of €49.1m in sales of prescription pharmaceuticals, or 8% over the same period last year

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Generics Bulletin for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Earnings

More from Business